IP Library Granted Patent US 8,653,058
Granted Patent B2
US 8,653,058 · App. 13/207,337 · Granted Feb 18, 2014

Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits

Inventors: Robert Emil Hodge (Thousand Oaks, CA); Jeffrey Douglas Webster (Thousand Oaks, CA); Robert M. Moriarty (Michiana Shores, IN)
Assignee: Kythera Biopharmaceuticals, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,653,058
App. No.
13/207,337
Granted
Feb 18, 2014
Kind
B2
Abstract

The present application is directed to an aqueous pharmaceutical composition comprising from about 0.4% w/v to less than about 2% w/v of a salt of deoxycholic acid, wherein the composition is maintained at a pH from about 8.1 to about 8.5 such that the composition is stabilized against precipitation. Also disclosed herein, are methods for stabilizing an aqueous pharmaceutical composition comprising from about 0.4% w/v to less than about 2% w/v of a salt of deoxycholic acid against precipitation, said method comprising maintaining pH of the solution from about 8.1 to about 8.5.

Claims (36)

1. A composition consisting of a salt of deoxycholic acid and a pharmaceutically acceptable excipient, wherein said composition contains 0.5%±0.1% of said salt which, when dissolved in water, is maintained at a pH of about 8.1 to about 8.5 and, when so maintained, said composition does not form a precipitate, and wherein said composition does not comprise phosphatidylcholine.

2. A composition consisting of a salt of deoxycholic acid and a pharmaceutically acceptable excipient, wherein said composition contains 1%±0.1% of said salt which, when dissolved in water, is maintained at a pH of about 8.1 to about 8.5 and, when so maintained, said composition does not form a precipitate, and wherein said composition does not comprise phosphatidylcholine.

3. The composition of claims 1 or 2 , wherein said excipient is a solvent, a buffer, a preservative, a lyophilization aid, or any combination thereof.

4. The composition of claim 3 , wherein said excipient is a solvent.

5. The composition of claim 4 , wherein said solvent is sterile water.

6. The composition of claim 3 , wherein said excipient is a preservative.

7. The composition of claim 6 , wherein said preservative is benzyl alcohol.

8. The composition of claim 7 , wherein said preservative is 0.9% benzyl alcohol.

9. The composition of claims 1 or 2 , wherein said composition has a pH of about 8.3.

10. A composition consisting of:

a sterile aqueous solution buffered to a pH of about 8.3;

0.5%±0.1% w/v of sodium deoxycholate;

about 0.9% w/v benzyl alcohol; and

about 1% w/v of sodium chloride,

wherein the composition is stable against precipitation, and wherein said composition does not comprise phosphatidylcholine.

11. A composition consisting of:

an aqueous solution buffered to a pH of about 8.3;

1%±0.1% w/v of sodium deoxycholate;

about 0.9% w/v benzyl alcohol; and

about 1% w/v of sodium chloride,

wherein the composition is stable against precipitation, and wherein said composition does not comprise phosphatidylcholine.

12. The composition of claim 1 or 2 , wherein said salt is an alkali metal salt.

13. The composition of claim 12 , wherein said alkali metal salt is sodium.

14. A composition consisting of:

a sterile aqueous solution buffered to a pH of about 8.3;

0.5%±0.1% w/v of sodium deoxycholate;

about 10 mM sodium phosphate;

about 0.9% w/v benzyl alcohol; and

about 75 mM of sodium chloride,

wherein the composition is stable against precipitation, and wherein said composition does not comprise phosphatidylcholine.

15. A composition consisting of:

a sterile aqueous solution buffered to a pH of about 8.3;

1%±0.1% w/v of sodium deoxycholate;

about 10 mM sodium phosphate; and

about 0.86% w/v of sodium chloride,

wherein the composition is stable against precipitation, and wherein said composition does not comprise phosphatidylcholine.

Assignments (3)
MERGER AND CHANGE OF NAME Recorded Nov 21, 2019
From: KYTHERA BIOPHARMACEUTICALS, LLC; ALLERGAN SALES, LLC
To: ALLERGAN SALES, LLC
Reel/Frame 051082/0509 →
CHANGE OF NAME Recorded Oct 9, 2019
From: KYTHERA BIOPHARMACEUTICALS, INC.
To: KYTHERA BIOPHARMACEUTICALS, LLC
Reel/Frame 051796/0667 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 21, 2011
From: HODGE, ROBERT EMIL; WEBSTER, JEFFREY DOUGLAS; MORIARTY, ROBERT M.
To: KYTHERA BIOPHARMACEUTICALS, INC.
Reel/Frame 027101/0694 →
Continuity (3)
Continuation In Part PCTUS2011031284 · Apr 5, 2011
Provisional Application 61483008 · May 5, 2011
Related Publication 20120258943A1 · Oct 11, 2012